Relación de la tensión de oxígeno cavernosa con la disfunción créctil de origen vascular

Archivos Espanoles de Urologia

Volumn 51, Issue 9, 1998, Pages 919-922

  Romero Tejada, Juan Carlos ^a,b   Borrell, Atanasio Fernández ^a   Arjona, Manuel Fernández ^a   Sanz, Ignacio Pereira ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; INJECTION; MALE; MIDDLE AGED; ORGANIC IMPOTENCE; OXYGEN CONSUMPTION; PENIS; PRESSURE; VASCULARIZATION;

ADULT; ALPROSTADIL; HUMANS; IMPOTENCE, VASCULOGENIC; INJECTIONS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PARTIAL PRESSURE; PENIS; VASODILATOR AGENTS;

EID: 0006186555     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. LUE, T. F. y TANAGHO, E. A.: "Physiology of erection and pharmacological management of impotence." J. Urol., 137: 829, 1987.
2. KRANE, R. J.; GOLDSTEIN, I. y SÁENZ DE TEJADA, L: "Impotence." N. Engl. J. Med., 321: 1.648, 1989.
3. PAICK, J. -S.; GOLDSMITH, P. C.; BATRA, A. K. y cols.: "Relationship between venous incompetence and cavernous nerve injury: ultrastructural alteration of cavernous smooth muscle in the neurotomized dog." Int. J. Impotence Res., 3: 185, 1991.
4. KIM, N.; VARDI, Y.; PADMA-NATHAN, H. y cols.: "Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection." J. Clin. Invest., 91: 437, 1993.
5. BURNETT, A. L.; LOWENSTEIN, C. J.; BREDT, D. S. y cols.: "Nitric oxide: a physiologic mediator of penile erection." Science, 257: 401, 1992.
6. VARDI, Y.: "Role of oxygen tension in the diagnosis of vasculogenic impotence." In: The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction. Edited by I. Goldstein and T. F. Lue. Kalamazoo, Michigan: Excerpta Medica, pp. 84-94, 1993
7. PERSSON, C.; DIEDERICHS, W.; LUE, T. F. y cols.: "Correlation of altered penile ultrastructure with clinical arterial evaluation." J. Urol., 142: 1.462, 1989.
8. ANDERSSON, K-E; HOLMQUIST, R: "Mechanisms for contraction and relaxation of human penile smooth muscle." Int. J. Impotence Res., 2: 209, 1990.
9. BURNETT, A. L.; LOWENSTEIN, C. J.; BREDT, D. S. y cols.: "Nitric oxide: a physiological mediator of penile erection." Science, 257: 401, 1992.
10. LERNER, S. E.; MELMAN, A.; CHRIST, G. J.: "A review of erectile dysfunction: new insights and more questions." J. Urol., 149: 1.246, 1993.
11. SÁENZ DE TEJADA, I.; GOLDSTEIN, I.; AZADZOI, K. y cols.: "Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence." N. Engl. J. Med., 320: 1.025, 1989.
12. STARR, A. A.; SALPIGIDES, G.; VANDERHAEGHEN, J. J. y cols.: "Cavernous oxygen tension and smooth muscle fibers: relation and function." J. Urol., 154: 1.736, 1995.
13. PICKARD, R. S.; KING, P.; ZAR, M. A. y cols.: "Corpus cavernosal relaxation in impotent men." Br. J. Urol., 74: 485, 1994.
14. KIM, N.; AZADZOI, K. M.; GOLDSTEIN, I. y cols.: "A nitric oxide-like factor mediates non-adrenergic, non-cholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle." J. Clin. Invest., 88: 112, 1991.
15. PICKARD, R. S.; POWELL, P. H.; ZAR, M. A.: "The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle." Br. J. Pharmacol., 104: 755, 1991.
16. RAJFER, J.; ARONSON, W. J.; BUSH, P. A. y cols.: "Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to non-adrenergic, non-cholinergic neurotransmission." N. Engl. J. Med., 326: 90, 1992.
17. BURNETT, A. L.; TILLMAN, S. L.; CHANG, T. S. K. y cols.: "Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis." J. Urol, 150: 73, 1993.
18. IGNARRO, L. J.; BUSH, P. A.; BUGA, G. M. y cols.: "Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle." Biochem. Biophys. Res. Commun.; 170: 843, 1990.
19. AZADZOI, K. M.; KIM, N.; BROWN, M. L. y cols.: "Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone." J. Urol., 147: 220, 1992.
20. GOLDSTEIN, A. M. B. y PADMA-NATHAN, H.: "The microarchitecture of the intracavernosal smooth muscle and the cavernosal fibrous skeleton." J. Urol., 144: 1.144, 1990.
21. SÁENZ DE TEJADA, I.; CARSON, M. P.; GOLDSTEIN, I. y cols.: "Endothelin: localization, synthesis, activity and receptor types in human penile corpus cavernosum." Am. J. Physiol., 261: H1078, 1991.
22. WESPES, E.; DE GOES, P. M.; SCHIFFMANN, S. y cols.: "Computerized analysis of smooth muscle fibres in potent and impotent patients." J. Urol., 146: 1.015, 1991.
23. WESPES, E.; DEPIERREUX, M.; SCHULMAN, C. C.: "Use of Biopty gun for corpus cavenosum biopsies." Eur. Urol., 18: 81, 1990.
24. GOLDSTEIN A. M. B.; MEEHAN, J. P.; ZAKHARY, R. y cols.: "New observations on microarchitecture of corpora cavernosa in man and possible relationship to mechanism of erection." Urology, 20: 259, 1982.
25. WESPES, E.; SCHULMAN, C. C.: "Venous impotence: pathophysiology, diagnosis and treatment." J. Urol., 149: 1.238, 1993.